BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15729073)

  • 1. CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.
    Duxbury MS; Matros E; Clancy T; Bailey G; Doff M; Zinner MJ; Ashley SW; Maitra A; Redston M; Whang EE
    Ann Surg; 2005 Mar; 241(3):491-6. PubMed ID: 15729073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma.
    Strickland LA; Ross J; Williams S; Ross S; Romero M; Spencer S; Erickson R; Sutcliffe J; Verbeke C; Polakis P; van Bruggen N; Koeppen H
    J Pathol; 2009 Jul; 218(3):380-90. PubMed ID: 19334050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
    Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
    Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Chosen Carcinoembryonic-Related Cell Adhesion Molecules in Pancreatic Intraepithelial Neoplasia (PanIN) Associated with Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma (PDAC).
    Zińczuk J; Zaręba K; Romaniuk W; Kamińska D; Nizioł M; Baszun M; Kędra B; Guzińska-Ustymowicz K; Pryczynicz A
    Int J Med Sci; 2019; 16(4):583-592. PubMed ID: 31171910
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.
    Duxbury MS; Matros E; Ito H; Zinner MJ; Ashley SW; Whang EE
    Ann Surg; 2004 Oct; 240(4):667-74; discussion 675-6. PubMed ID: 15383794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma.
    Park SJ; Gu MJ; Lee DS; Yun SS; Kim HJ; Choi JH
    Int J Clin Exp Pathol; 2015; 8(7):8298-304. PubMed ID: 26339400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of CEACAM6 and FOXP3 on tumor infiltrating lymphocytes and prognosis in patients with pancreatic cancer].
    Zhang K; Liu Y; Jin C; Gu D; Xia T; Ye J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Aug; 31(8):1103-7. PubMed ID: 26271985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers.
    Tsang JY; Kwok YK; Chan KW; Ni YB; Chow WN; Lau KF; Shao MM; Chan SK; Tan PH; Tse GM
    Breast Cancer Res Treat; 2013 Nov; 142(2):311-22. PubMed ID: 24186057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Jul; 23(34):5834-42. PubMed ID: 15208677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling of CEACAM6 associated with the tumorigenesis and progression in gastric adenocarcinoma.
    Deng X; Liu P; Zhao Y; Wang Q
    Genet Mol Res; 2014 Sep; 13(3):7686-97. PubMed ID: 25299082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.
    Bergmann F; Wandschneider F; Sipos B; Moldenhauer G; Schniewind B; Welsch T; Schirrmacher P; Klöppel G; Altevogt P; Schäfer H; Sebens Müerköster S
    Oncol Rep; 2010 Oct; 24(4):909-15. PubMed ID: 20811670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance.
    Jantscheff P; Terracciano L; Lowy A; Glatz-Krieger K; Grunert F; Micheel B; Brümmer J; Laffer U; Metzger U; Herrmann R; Rochlitz C
    J Clin Oncol; 2003 Oct; 21(19):3638-46. PubMed ID: 14512395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Jan; 23(2):465-73. PubMed ID: 14724575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
    Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
    Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.
    Blumenthal RD; Leon E; Hansen HJ; Goldenberg DM
    BMC Cancer; 2007 Jan; 7():2. PubMed ID: 17201906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
    Fong D; Spizzo G; Mitterer M; Seeber A; Steurer M; Gastl G; Brosch I; Moser P
    Ann Surg Oncol; 2012 Dec; 19(13):4330-6. PubMed ID: 22549289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell motility and spreading promoted by CEACAM6 through cyclin D1/CDK4 in human pancreatic carcinoma.
    Yan L; Wang Y; Wang ZZ; Rong YT; Chen LL; Li Q; Liu T; Chen YH; Li YD; Huang ZH; Peng J
    Oncol Rep; 2016 Jan; 35(1):418-26. PubMed ID: 26497080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma.
    Sakugawa C; Haruyama Y; Tanaka H; Fukushima T; Kawaguchi M; Kataoka H
    BMC Res Notes; 2017 Dec; 10(1):674. PubMed ID: 29202869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Benoit E; Ashley SW; Whang EE
    Br J Cancer; 2004 Oct; 91(7):1384-90. PubMed ID: 15316565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells.
    Iwabuchi E; Miki Y; Onodera Y; Shibahara Y; Takagi K; Suzuki T; Ishida T; Sasano H
    Clin Exp Metastasis; 2019 Oct; 36(5):423-432. PubMed ID: 31222613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.